• Comparison of Two Strategies of One-lung Ventilation in Patients Undergoing Carcinological Lung Resection Surgery.

  NCT05525312

  RecruitingInterventionalNot ApplicableUpdated Mar 31, 2026
• Non-Invasive Ventilation Preoperative Lung Resection Surgery

  NCT01685580

  CompletedInterventionalNot ApplicableUpdated Dec 3, 2025
• Noninvasive Ventilatory Support After Lung Surgery in COPD Patients

  NCT00428857

  CompletedInterventionalNot ApplicableUpdated Feb 24, 2011
• Individualized Perioperative Open Lung Ventilatory Strategy

  NCT02158923

  CompletedInterventionalNot ApplicableUpdated May 17, 2016
• The PROtective Ventilation Using Open Lung Approach Or Not Trial

  NCT03160144

  CompletedInterventionalNot ApplicableUpdated Dec 3, 2019
• Functional Residual Capacity and Alveolar Recruitment in Single-lung Ventilation: a Randomized Study

  NCT06446544

  Not yet recruitingInterventionalNot ApplicableUpdated Jun 9, 2026

ClinicalTrials.gov ID

NCT07247500

Lead Sponsor

University Hospital, RouenOTHER

Overall Status

Not yet recruiting

Study Type

Interventional

Phase

Not Applicable

Enrollment

350Estimated

Last Update Posted

Jun 9, 2026Actual

Start Date

Jul 1, 2026Estimated

Primary Completion Date

Jul 8, 2028Estimated

Completion Date

Aug 1, 2028Estimated

Official Title

Impact of Reventilation After One-Lung Ventilation in Thoracic Surgery (OLVREEXP)

Brief Summary

Lung cancer is a common disease, and more than 8,000 patients in France undergo lobectomy or pulmonary segmentectomy each year. This surgery remains associated with significant postoperative pulmonary complications, whose incidence ranges from 15% to 49% depending on the study (1). The main complication is pulmonary atelectasis, which provides a favorable setting for the development of postoperative pneumonia.

In thoracic surgery, the operated lung is excluded, and one-lung ventilation is performed on the contralateral lung. During surgery, several strategies exist to prevent atelectasis during one-lung ventilation, known as protective ventilation strategies (2). At the end of the procedure, reventilation allows re-expansion of the previously excluded lung.

However, pulmonary reventilation induces the release of pro-inflammatory cytokines and causes endothelial dysfunction, which may lead to pulmonary edema, thereby negating the benefits of intraoperative protective ventilation. Conversely, insufficient re-expansion may result in persistent postoperative atelectasis, whereas excessive re-expansion can cause volutrauma, alveolar trauma, and/or barotrauma to the operated lung (3).

Several reventilation techniques are currently used, but to our knowledge, the impact of reventilation itself has never been specifically studied. The first, empirical technique, consists of reventilating both lungs using the accessory circuit and the adjustable pressure-limiting (APL) valve, manually bagging the patient over several respiratory cycles (4). The main drawback of this method is the lack of monitoring of insufflated volumes and pressures.

The second, more recent technique, consists of reventilating the patient using the anesthesia machine circuit in controlled ventilation mode, which allows for precise monitoring of pressures and insufflated volumes (5). This approach provides real-time monitoring of lung re-expansion and could therefore be less harmful than the empirical method.

Thus, the objective of this study is to compare postoperative pulmonary complications between patients who underwent lung re-expansion using the accessory circuit and those who underwent lung re-expansion using the anesthesia machine circuit in controlled ventilation mode.

• Lung Surgery

• Bipulmonary Reventilation using the accessory circuit
• Bipulmonary Reventilation under controlled ventilation

Ages Eligible for Study

Adult (18-64)Older Adult (65+)

Sexes Eligible for Study

All

Accepts Healthy Volunteers

No

Eligibility Criteria

Inclusion Criteria:

• ASA score ≤ 3.
• Undergoing a scheduled video-assisted or robot-assisted lobectomy or segmentectomy.
• Patient has read and understood the information sheet and signed the informed consent form.
• For women of childbearing potential, effective contraception and confirmation of the absence of an ongoing pregnancy by a negative blood or urine pregnancy test are required.
• Postmenopausal women (spontaneous, non-medically induced amenorrhea for at least 12 months prior to the inclusion visit).
• Patient affiliated with a social security system.

Exclusion Criteria:

• Patients with a BMI > 40 kg/m².
• Patients with severe chronic respiratory failure (COPD grade 3, FEV₁/FVC < 0.7 and FEV₁ < 50% - according to the GOLD 2025 classification).
• Patients with severe chronic renal failure (GFR < 30 mL/min).
• Patients at high risk of conversion to thoracotomy.
• Patients with a history of acute respiratory distress syndrome (ARDS) within 3 months prior to surgery.
• Patients with a known history of severe hepatic failure (Child-Pugh class B or C).
• Patients with a history of heart failure (NYHA class ≥ II).
• Patients with a history of pulmonary resection.
• Patients with uncontrolled asthma.
• Pregnant or breastfeeding women.
• Patients deprived of liberty by administrative or judicial decision, as well as those under legal protection, guardianship, or curatorship.

Primary Purpose

Supportive Care

Allocation

Randomized

Interventional Model

Parallel Assignment

Masking

None (Open Label)

Lead Sponsor

University Hospital, RouenOTHER

huette.pierre@gmail.com03 22 33 71 05

mouhamed.moussa@chru-lille.fr03 20 44 59 62

jean.selim@chu-rouen.fr

s.martins@hopital-foch.com01 46 25 24 33